p21WAF1基因与肝细胞癌临床病理特征的相关性分析.pdf

ma[J].Hepatology,1997,25:575.2ZolotaV,BatistatouA,TsamandasA,eta1.ImmunohistochemicalexpressionofTGF—beta1,p21WAF1,p21WAF1,Ki67,andangio-arcinomas:aclinic0path0l0gicstudy[J].IntJGas-trointestCancer,2003,32:83—90.3HuiAM,KanaiY,Sakamo~oM,eta1.Reducedp21[WAF1/CIP1]expressionandp53mutationinhepatocellularcarcinoma[J].Hepatology,1997,25:575.4MichieliP,ChedidM,LinD,eta1.InductionofWAF/CIP1byap53一independentpathway[J].CancerRes,1995,5:884—888.5SteinmanRA,JohnsonDE.p21WAF1preventsdown—modulationoftheapoptoticinhibitorproteinc—IAP1andinhibitsleukemicapoptosis[J].MolMed,2000,6:736—749.6谢海龙,苏琦,贺修胜,等.p21WAF1基因多态性与胃癌易感性关系癌症研究[J].中国肿瘤临床,2002,5(10):164—165.7李仲宏,金亦.乳腺癌p21WAF1基因多态性及其临床意义[J].中华实验外科杂志,2001,18:524—525.8王其春,李国平,闰静,等.肝细胞癌患者血液循环中VEGF的检测及临床意义[J].中国误诊学杂志,2004,4:1281.(收稿日期:2007~11~08)(本文编辑:康丽涛)维普资讯